Are you involved in a drug development project? Do you know the way to go and what to expect?
In this SPARK Europe Webinar, Dr. Sara Blumenstein, pharma and biotechnology regulatory section manager at Gsap, will guide us through the journey of drug development -from discovery to market. Sara has over 20 years of experience as regulatory project manager in the fields of biotechnology and cell therapies, hence after her lecture you will have gained insights into:
- Types of drugs and biologics
- Regulatory pathways
- Drug development process
- Additional aspects and examples of FDA-approved drugs and biologics
The Webinar will be hosted by SPARK Tel Aviv.
Online via Zoom ǀ Please register here!
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
